Health In Tech Reports $8.8 Million Revenue for Q1 2026

Health In Tech announced in a press release its unaudited financial results for the first quarter of 2026, reporting revenue of $8.8 million, up 9.4% from $8.0 million in the same period of 2025. The company recorded a net loss of $1.6 million, or $0.03 per diluted share, compared to net income of $0.5 million, or $0.01 per share, a year earlier.

Adjusted EBITDA was negative $1.3 million, down from positive $1.2 million in the first quarter of 2025. The company attributed the decline to higher sales and marketing spending aimed at supporting long term revenue growth. Platform placed plan value totaled $82.0 million.

As of March 31, 2026, Health In Tech had 896 distribution partners, including brokers, third party administrators, and agencies, representing a 29.5% increase from 692 partners a year earlier. Contracted revenue for the remaining three quarters of 2026 stood at $22.9 million. Cash and cash equivalents reached $10.3 million, up from $7.6 million in the previous year, while working capital increased to $15.0 million from $8.8 million.

The company reaffirmed its full year 2026 revenue guidance of $45 million to $50 million, which would represent growth of approximately 35% to 50% year over year. Continued expansion of its distribution network and the rollout of new features launched in January 2026 are expected to support this outlook.